Eli Lilly & Co. vs. NewAmsterdam Pharma Company N.V. Ordinary Shares
LLY
Eli Lilly & Co.
$1411.95 +4.28%
VS NAMSNewAmsterdam Pharma Company N.V. Ordinary Shares
$18.90 +0.05%
Eli Lilly & Co. and NewAmsterdam Pharma Company N.V. Ordinary Shares are evenly matched on the factors we track — the better pick depends on what you're optimizing for.
Size & Scale
| LLY | NAMS | |
|---|---|---|
| Market Cap | $1.26 trillion | $2.27 billion |
LLY leads on 1 of 1 size & scale factors.
Dividend
| LLY | NAMS | |
|---|---|---|
| Dividend Yield | 0.49% | — |
LLY and NAMS split the dividend factors evenly.
Risk & Sentiment
| LLY | NAMS | |
|---|---|---|
| Short Interest | 1.29% | 0.01% |
NAMS leads on 1 of 1 risk & sentiment factors.
Dig deeper: LLY overview, LLY financials, NAMS overview, NAMS financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.